Possible association of killer cell immunoglobulin-like receptor genotypes and haplotypes with dry eye disease in a Han Chinese population

Molecular Vision

Volumn 21, Issue , 2015, Pages 948-954

  Ren, Guifang ^a   Li, Huiyu ^b   Qiao, Wenben ^c   Shen, Hua ^c   Zhuang, Yunlong ^c   Shao, Tiejun ^a   Hu, Haipeng ^a   Zhang, Xiuping ^a  

^a Ophthalmology Department   (China)

^b UNIVERSITY OF MINNESOTA   (United States)

^c Blood Center of Shandong Province   (China)

Author keywords

[No Author keywords available]

Indexed keywords

KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR;

ARTICLE; CAUCASIAN; DISEASE SEVERITY; DRY EYE; FEMALE; GENE FREQUENCY; GENETIC VARIABILITY; GENOTYPE; HAN CHINESE; HAPLOTYPE; HUMAN; KIR GENE; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; POPULATION RESEARCH; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; ASIAN CONTINENTAL ANCESTRY GROUP; CASE CONTROL STUDY; CHINA; GENETIC ASSOCIATION STUDY; GENETICS; IMMUNOLOGY;

ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CHINA; DRY EYE SYNDROMES; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENOTYPE; HAPLOTYPES; HUMANS; MALE; RECEPTORS, KIR; RISK FACTORS;

EID: 84940179910     PISSN: None     EISSN: 10900535     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Gayton JL. Etiology, prevalence, and treatment of dry eye disease. Clin Ophthalmol 2009; 3:405-12. [PMID: 19688028].
2. Miljanović B, Dana R, Sullivan DA, Schaumberg DA. Impact of dry eye syndrome on vision-related quality of life. Am J Ophthalmol 2007; 143:409-15. [PMID: 17317388].
3. Chen Y, Chauhan SK, Saban DR, Sadrai Z, Okanobo A, Dana R. Interferon-γ-secreting NK cells promote induction of dry eye disease. J Leukoc Biol 2011; 89:965-72. [PMID: 21402771].
4. Luo L, Li DQ, Doshi A, Farley W, Corrales RM, Pflugfelder SC. Experimental dry eye stimulates production of infl ammatory cytokines and MMP-9 and activates MAPK signaling pathways on the ocular surface. Invest Ophthalmol Vis Sci 2004; 45:4293-301. [PMID: 15557435].
5. Solomon A, Dursun D, Liu Z, Xie Y, Macri A, Pflugfelder SC. Pro-and anti-infl ammatory forms of interleukin-1 in the tear fl uid and conjunctiva of patients with dry-eye disease. Invest Ophthalmol Vis Sci 2001; 42:2283-92. [PMID: 11527941].
6. Yagci A, Gurdal C. The role and treatment of inflammation in dry eye disease. Int Ophthalmol 2014; 34:1291-301. [PMID: 25416345].
7. Zhuang YL, Song Y, Zhu C, Zhang Y, Wang D, Nie X, Liu Y, Ren GJ. Association of KIR genotypes and haplotypes with syphilis in a Chinese Han population. Scand J Immunol 2012; 75:361-7. [PMID: 22126195].
8. Cooley S, Weisdorf DJ, Guethlein LA, Klein JP, Wang T, Le CT, Marsh SG, Geraghty D, Spellman S, Haagenson MD, Ladner M, Trachtenberg E, Parham P, Miller JS. Donor selection for natural killer cell receptor genes leads to superior survival after unrelated transplantation for acute myelogenous leukemia. Blood 2010; 116:2411-9. [PMID: 20581313].
9. Uhrberg M, Parham P, Wernet P. Definition of gene content for nine common group B haplotypes of the Caucasoid population: KIR haplotypes contain between seven and eleven KIR genes. Immunogenetics 2002; 54:221-9. [PMID: 12136333].
10. Shilling HG, Young N, Guethlein LA, Cheng NW, Gardiner CM, Tyan D, Parham P. Genetic control of human NK cell repertoire. J Immunol 2002; 169:239-47. [PMID: 12077250].
11. Shastry A, Sedimbi SK, Rajalingam R, Rumba I, Kanungo A, Sanjeevi CB. Different KIRs confer susceptibility and protection to adults with latent autoimmune diabetes in Latvianand Asian Indian populations. Ann N Y Acad Sci 2008; 1150:133-8. [PMID: 19120281].
12. Parham P. MHC class I molecules and KIRs in human history, health and survival. Nat Rev Immunol 2005; 5:201-14. [PMID: 15719024].
13. Carrington M, Martin MP. The impact of variation at the KIR gene cluster on human disease. Curr Top Microbiol Immunol 2006; 298:225-57. [PMID: 16329188].
14. Suzuki Y, Hamamoto Y, Ogasawara Y, Ishikawa K, Yoshikawa Y, Sasazuki T, Muto M. Genetic polymorphisms of killer cell immunoglobulin-like receptors are associated with susceptibility to psoriasis vulgaris. J Invest Dermatol 2004; 122:1133-6. [PMID: 15140215].
15. Boyton RJ, Smith J, Ward R, Jones M, Ozerovitch L, Wilson R, Rose M, Trowsdale J, Altmann DM. HLA-C and killer cell immunoglobulin-like receptor genes in idiopathic bronchiectasis. Am J Respir Crit Care Med 2006; 173:327-33. [PMID: 16254274].
16. Jennes W, Verheyden S, Demanet C, Adjé-Touré CA, Vuylsteke B, Nkengasong JN, Kestens L. Cutting edge: resistance to HIV-1 infection among African female sex workers is associated with inhibitory KIR in the absence of their HLA ligands. J Immunol 2006; 177:6588-92. [PMID: 17082569].
17. Ren G, Shao T, Zhuang Y, Hu H, Zhang X, Huang J, Liu Y, Liu D. Association of killer cell immunoglobulin-like receptor and human leukocyte antigen-C genotype with dry eye disease in a Chinese Han population. Genet Test Mol Biomarkers 2012; 16:910-4. [PMID: 22509813].
18. Hsu KC, Liu XR, Selvakumar A, O'Reilly RJ, Dupont B. Killer Ig-like receptor haplotype analysis by gene content: evidence for genomic diversity with a minimum of six basic framework haplotypes, each with multiple subsets. J Immunol 2002; 169:5118-29. [PMID: 12391228].
19. Marsh SG, Parham P, Dupont B, Geraghty DE, Trowsdale J, Middleton D, Vilches C, Carrington M, Witt C, Guethlein LA, Shilling H, Garcia CA, Hsu KC, Wain H. Killer-cell immunoglobulin-like receptor (KIR) nomenclature report, 2002. Hum Immunol 2003; 64:648-54. [PMID: 12770798].
20. Kulkarni S, Martin MP, Carrington M. The Yin and Yang of HLA and KIR in human disease. Semin Immunol 2008; 20:343-52. [PMID: 18635379].
21. Gao X, Jiao Y, Wang L, Liu X, Sun W, Cui B, Chen Z, Zhao Y. Inhibitory KIR and specific HLA-C gene combinations confer susceptibility to or protection against chronic hepatitis B. Clin Immunol 2010; 137:139-46. [PMID: 20643584].
22. Wauquier N, Padilla C, Becquart P, Leroy E, Vieillard V. Association of KIR2DS1 and KIR2DS3 with fatal outcome in Ebola virus infection. Immunogenetics 2010; 62:767-71. [PMID: 20878400].
23. Nelson GW, Martin MP, Gladman D, Wade J, Trowsdale J, Carrington M. Cutting edge: heterozygote advantage in autoimmune disease: hierarchy of protection/susceptibility conferred by HLA and killer Ig-like receptor combinations in psoriatic arthritis. J Immunol 2004; 173:4273-6. [PMID: 15383555].
24. Lu Z, Zhang B, Chen S, Gai Z, Feng Z, Liu X, Liu Y, Wen X, Li L, Jiao Y, Ma C, Shao S, Cui X, Chen G, Li J, Zhao Y. Association of KIR genotypes and haplotypes with susceptibility to chronic hepatitis B virus infection in Chinese Han population. Cell Mol Immunol 2008; 5:457-63. [PMID: 19118512].
25. Napierala MA. What Is the Bonferroni Correction? AAOS Now 2012; 6:40-5.